Logo-jcvtr

J Cardiovasc Thorac Res. 2017;9(2): 85-89. doi: 10.15171/jcvtr.2017.14
PMID: 28740627        PMCID: PMC5516056

Original Article

Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients

Lucky R. Cuenza 1 * , Tamara Louise J. Razon 2, Juan Carlo Dayrit 3

Cited by CrossRef: 13

1- Villani R, Magnati G, Tuccari G, Sangineto M, Romano A, Cassano T, Serviddio G. Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice. Ultrasound. 2023;31(3):177 [Crossref]
2- Kweon Y, Ko H, Kim A, Choi H, Song J, Park J, Kim S, Hong H, Min K. Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems. Healthcare. 2021;9(7):899 [Crossref]
3- Popović D, Rošić S, Lukić S. Incidence of different types of irritable bowel syndrome in patients with nonalcoholic fatty liver. Medicinski podmladak. 2022;73(2):6 [Crossref]
4- Tana C, Ballestri S, Ricci F, Di Vincenzo A, Ticinesi A, Gallina S, Giamberardino M, Cipollone F, Sutton R, Vettor R, Fedorowski A, Meschi T. Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. IJERPH. 2019;16(17):3104 [Crossref]
5- Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim C. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. F1000Res. 2017;6:1630 [Crossref]
6- Liu X, Yao Z, Li N, Gao K, Zhu S, Ramirez G. Study on the Correlation between Nonalcoholic Fatty Liver and Metabolic Syndrome Based on Magnetic Resonance Diffusion-Weighted Imaging. Scientific Programming. 2021;2021:1 [Crossref]
7- AkbariRad M, Pezeshki Rad M, Nobakht H, Moodi Ghalibaf A, Firoozi A, Torshizian A, Bina A, Beheshti Namdar A, Sadeghi M. Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study. BMC Gastroenterol. 2024;24(1) [Crossref]
8- Tutunchi H, Saghafi-Asl M, Asghari-Jafarabadi M, Ostadrahimi A. The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults. BMC Res Notes. 2020;13(1) [Crossref]
9- Belinchón-Romero I, Bellot P, Romero-Pérez D, Herraiz-Romero I, Marco F, Frances R, Ramos-Rincón J. Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients. Sci Rep. 2021;11(1) [Crossref]
10- Al Ghaithi F, Waly M, Al-Farsi Y, Al Mukhaini Z, Al Balushi R, Almashrafi A. Biochemical and nutritional determinants of non-alcoholic fatty liver disease in Omani adult patients: a case-control study. 2024;14(4):407 [Crossref]
11- BEKTAS A, ULUSOY M, DAĞALP K. Ursodeoksikolik Asit, Diyabetik Olmayan, Alkol Dışı Karaciğer Yağlanması Tedavisinde Yer Almalı Mı?. 2020;12(1):44 [Crossref]
12- Zafar U, Ahmad M, Nadeem N, Muhammad Zohaib Uddin M, Zafar B, Baig S, Zafar F, Pervez H, Akram S. Correlation of Grades of Non-alcoholic Fatty Liver on Ultrasound With Blood Parameters. 2024; [Crossref]
13- Maev I, Samsonov A, Palgova L, Pavlov C, Vovk E, Shirokova E, Starostin K. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterol. 2020;7(1):e000341 [Crossref]
14- Ballestri S, Tana C, Di Girolamo M, Fontana M, Capitelli M, Lonardo A, Cioni G. Semi-Quantitative Ultrasonographic Evaluation of NAFLD. CPD. 2020;26(32):3915 [Crossref]
15- Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim C. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. F1000Res. 2017;6:1630 [Crossref]
16- Larion S, Padgett C, Mintz J, Thompson J, Butcher J, Belin de Chantemèle E, Haigh S, Khurana S, Fulton D, Stepp D. NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024;326(3):G264 [Crossref]
17- El-Sehrawy A, State O, Elzehery R, Mohamed A. Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome. Horm Metab Res. 2021;53(02):100 [Crossref]
18- 苏热亚 ·. Research Progress on the Correlation between Nonalcoholic Fatty Liver and Ejection Fraction Preservation Heart Failure. ACM. 2024;14(01):1104 [Crossref]